학술논문

Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 1 April 2023, 41(10):1876-1887)
Subject
Language
English
ISSN
15277755
0732183X